Product Description
Product introduction
Puregraf 75IU HP Injection is used in the treatment of infertility in women. It is also helpful in the treatment of male hypogonadism (delayed puberty and low sperm count) and male infertility. It works by releasing the eggs from the ovary in women and by increasing the testosterone level in men.
Effective Therapy for Female InfertilityPuregraf 75 IU HP Injection contains highly purified menotrophin, proven to support the development of ovarian follicles. It is primarily recommended for women experiencing anovulation or those undergoing Assisted Reproductive Techniques (ART). The treatment aids in stimulating the ovaries to boost reproductive potential, significantly increasing the chances of conception under medical guidance.
Easy-to-Use Reconstitution ProcessEach package comes with a lyophilized powder vial and a solvent ampoule. Prior to administration, the powder should be carefully reconstituted using the provided solvent as instructed by a healthcare professional. The resulting solution is then injected intramuscularly or subcutaneously, depending on your doctor's recommendation, ensuring consistent and effective dosing.
Strict Quality and Safety StandardsWith a shelf life of 24 months from the manufacturing date, Puregraf 75 IU HP is strictly regulated, requiring a prescription and offering clear dosage guidelines for adults. The product is manufactured in India and distributed worldwide, with instructions to store it in a refrigerator and protect it from light, guaranteeing its stability and efficacy throughout its intended use.
FAQ's of Puregraf 75 Iu Hp Injection:
Q: How should Puregraf 75 IU HP Injection be administered?
A: Puregraf 75 IU HP Injection must be administered either intramuscularly or subcutaneously, following reconstitution with the included solvent. Always ensure the injection is given by a qualified healthcare provider.
Q: What is the main benefit of using Puregraf 75 IU HP Injection?
A: The primary benefit of Puregraf 75 IU HP Injection is its ability to stimulate follicular development in the ovaries, which is essential for treating female infertility and enhancing the success rates of Assisted Reproductive Techniques (ART).
Q: When is Puregraf 75 IU HP Injection typically recommended?
A: This injection is recommended for adult women with infertility due to anovulation or those requiring controlled ovarian hyperstimulation during ART procedures, as directed by a fertility specialist.
Q: What process should be followed to prepare Puregraf 75 IU HP Injection?
A: Before injection, dissolve the white to off-white powder using the supplied ampoule of solvent. Ensure the entire contents are mixed gently and the solution is clear, in line with your doctor's instructions.
Q: Where should Puregraf 75 IU HP Injection be stored?
A: Store Puregraf 75 IU HP Injection in a refrigerator at 2C - 8C. Avoid freezing the product and always keep it protected from light to maintain its effectiveness.
Q: Who should avoid using Puregraf 75 IU HP Injection?
A: This medication is contraindicated for individuals with a known hypersensitivity to menotrophins, women experiencing ovarian enlargement, or those who are pregnant. Use solely under medical supervision.
Q: What are the possible side effects of Puregraf 75 IU HP Injection?
A: Some users may experience abdominal pain, bloating, headaches, or injection site reactions. If you encounter severe side effects, contact your healthcare provider immediately.